Finally, we demonstrate that AAV-based delivery of DNAJB6 rescues motor neuron loss and associated microgliosis in a mouse model of ALS-FUS, demonstrating its therapeutic potential in vivo. This evidence concerns the gene DNAJB6 and amyotrophic lateral sclerosis.